Vertex Pharmaceuticals VRTX: A Biotech Company on the Rise
October 24, 2025
Vertex Pharmaceuticals Incorporated: A Leader in Biotechnology Innovation
October 9, 2025
Vertex Pharmaceuticals Incorporated VRTX - Leading the Way in Rare Disease Treatments
August 15, 2025
VERTEX PHARMACEUTICALS INCORPORATED Hits 10.2% Profit Target Forecast by QuantWave
August 8, 2025
VERTEX PHARMACEUTICALS Stock Hits Target Forecast with 8.98% Profit
August 8, 2025
VERTEX PHARMACEUTICALS Stock Hits Target Price with 10.23% Profit: QuantWave Forecast Success
August 8, 2025
Vertex Pharmaceuticals Incorporated VRTX - Leading the Way in Rare Disease Treatments
August 15, 2025
Vertex Pharmaceuticals Announces Impressive Q4 2024 Earnings and FDA Approval of Key Drugs
February 13, 2025
Vertex Pharmaceuticals Incorporated VRTX Reports Positive Outcomes from CFTR Modulator Studies
June 8, 2025
A Once-in-a-Generation Opportunity: Vertex Pharmaceuticals Inc. Shows Promise for Investors
January 7, 2025
VRTX Stock Down as Q1 Sales of New Drugs Miss Expectations
May 10, 2025
Investor opinions & comments
To leave a comment, you need to Login or Register.
ThomasHawkins
December 14, 2025 at 13:15
VRTX's dedication to patient care and innovation is commendable
EliWells
December 14, 2025 at 12:59
Excited to see how VRTX continues to innovate in healthcare
ProfitPam
December 13, 2025 at 19:21
I'm not sure if VRTX's advancements will truly make a difference in the healthcare industry
AvaTurner
December 13, 2025 at 12:35
Looking forward to seeing the new treatments VRTX has in store for patients
NicholasEdwards
December 12, 2025 at 17:05
I have confidence that VRTX will continue to make significant contributions to healthcare
SaraBrown
December 12, 2025 at 13:54
I hope VRTX's focus on innovation doesn't come at the expense of patient safety